Next Article in Journal
Compactness Aromaticity of Atoms in Molecules
Next Article in Special Issue
MDL-28170 Has No Analgesic Effect on CCI Induced Neuropathic Pain in Mice
Previous Article in Journal
Whole Cell Imprinting in Sol-Gel Thin Films for Bacterial Recognition in Liquids: Macromolecular Fingerprinting
Previous Article in Special Issue
trans-Resveratrol as A Neuroprotectant
Int. J. Mol. Sci. 2010, 11(4), 1253-1268; doi:10.3390/ijms11041253

A Novel PARP Inhibitor L-2286 in a Rat Model of Impact Acceleration Head Injury: An Immunohistochemical and Behavioral Study

1 Department of Neurosurgery, Medical Faculty, University of Pécs, 7623 Pécs, Hungary 2 Laboratoire de Pharmacologie de la Circulation Cérébrale, UPRES EA 2510, Université René Descartes, Paris, France 3 Department of BioChemistry, University of Pécs, 7624 Pécs, Hungary 4 Department of Experimental Zoology and Neurobiology, University of Pécs, 7624, Hungary
* Author to whom correspondence should be addressed.
Received: 3 November 2009 / Revised: 11 March 2010 / Accepted: 22 March 2010 / Published: 26 March 2010
(This article belongs to the Special Issue Neuroprotective Strategies (special issue))
View Full-Text   |   Download PDF [932 KB, uploaded 19 June 2014]   |   Browse Figures


We examined the neuro/axono-protective potential of a novel poly (ADP-ribose) polymerase (PARP) inhibitor L-2286 in a rat impact acceleration brain injury model. Male Wistar rats (n = 70) weighing 300-350 grams were used to determine the most effective intracerebroventricular (i.c.v.) dose of L-2286 administered 30 min after injury, and to test the neuroprotective effect at two time points (immediately, and 30 min after injury). The neuroprotective effect of L-2286 was tested using immunohistochemical (amyloid precursor protein and mid-sized mouse anti-neurofilament clone RMO-14.9 antibody) and behavioral tests (beam-balance, open-field and elevated plus maze). At both time-points, a 100 µg/rat dose of i.c.v. L-2286 significantly (p < 0.05) reduced the density of damaged axons in the corticospinal tract and medial longitudinal fascicle compared to controls. In the behavioral tests, treatment 30 min post-injury improved motor function, while the level of anxiety was reduced in both treatment protocols.
Keywords: PARP-inhibitor; impact acceleration model; traumatic brain injury PARP-inhibitor; impact acceleration model; traumatic brain injury
This is an open access article distributed under the Creative Commons Attribution License (CC BY) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote |
MDPI and ACS Style

Kövesdi, E.; Bukovics, P.; Besson, V.; Nyirádi, J.; Lückl, J.; Pál, J.; Sümegi, B.; Dóczi, T.; Hernádi, I.; Büki, A. A Novel PARP Inhibitor L-2286 in a Rat Model of Impact Acceleration Head Injury: An Immunohistochemical and Behavioral Study. Int. J. Mol. Sci. 2010, 11, 1253-1268.

View more citation formats

Related Articles

Article Metrics

For more information on the journal, click here


[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert